Thursday, June 17, 2021
Times of Georgia
HomeWorldAgilex Biolabs And Gyros Protein Technologies Partner For BioAnalysis Zone Webinar On...

Agilex Biolabs And Gyros Protein Technologies Partner For BioAnalysis Zone Webinar On Singlicate Analysis

ADELAIDE, AUS, May 31, 2021 – (ACN Newswire) – Agilex
Biolabs, Australia’s largest and most technologically
advanced specialist bioanalytical laboratory for clinical
trials is partnering with Gyros Protein Technologies and
BioAnalysis Zone to share the latest on singlicate analysis
on the Gyrolab platform.

Register Here

analysis on the Gyrolab platform

Wednesday 2 June

18:00 [EDT] 23:00 [BST] | Thursday 3 June 06:00
[CST] 08:00 [AEST]

Agilex Biolabs’ Principal Method
Development Scientist, Morgan Evans will present with Gyros
Protein Technologies’ Application & Service Director
EMEA and Asia Pacific, John Chappell for a comprehensive
webinar titled Singlicate analysis on the Gyrolab

The webinar topic was inspired by the Agilex
Biolabs poster presentation Development and Validation of a
PK Method for Tocilizumab in Both Singlicate and Duplicate
on the Gyrolab Platform presented at the 13th EBF open

Over the last several years singlet
analysis has become a hot topic within the world of LBA
non-regulated and regulated bioanalysis. A number of studies
have demonstrated positive outcomes on both replicate
precision assessment and PK/TK parameters.

Due to the
highly automated and robust nature of the instrument,
Gyrolab has become a front runner in LBA technologies for
singlicate analysis.

This webinar will look at the
overall landscape of singlet analysis and through Agilex
Biolabs case studies discuss the use of the Gyrolab
technology. It will also look at how lessons learned can
inform prospects of singlicate analysis on other
technological platforms keeping in mind ‘speed to patient’
to ensure efficiency in bioanalytical

Agilex Biolabs’ world-class laboratories
feature state-of-the-art equipment including Gyrolab Xplore,
MSD Quickplex 120, Luminex Magpix, BD FACSymphony A3 flow
cytometer and soon to be released, digital droplet
quantitative real-time RT-PCR.

The company offers
services for both small molecules and biologics for PK,
immunogenicity (PD) and biomarker bioanalysis utilising the
two platforms of LC-MS/MS and Immunoassay.

clinical trials have remained open for business and Agilex
Biolabs is a designated essential service so clients can be
assured of study continuity.

Agilex Biolabs has more
than 120 staff which includes 85 dedicated laboratory staff,
and supports client pharma and biotech companies from US,
Europe and APAC.

Book a confidential briefing with our
scientists before you start your next clinical

Agilex Biolabs —

Biolabs, Australia’s leading bioanalytical laboratory, has
more than 24 years’ experience in performing regulated
bioanalysis, including quality method development, method
validation and sample analysis services. It has successfully
supported hundreds of preclinical and clinical trials from
around the world where customers choose Australia for the
streamlined regulatory process and access to the world’s
most attractive R&D rebate of more than 40% on clinical
trial work conducted in Australia. Agilex Biolabs also
offers toxicology services through its company TetraQ, an
established GLP rodent toxicology facility in

Agilex Biolabs has the leading
certifications including OECD GLP Recognition with NATA
(Australian Government OECD GLP Compliance monitoring
authority) and ISO 17025 Accreditation for global
recognition. The company has recently expanded its main labs
by more than 30% to accommodate biotech demand from APAC and
the USA. Watch the new lab video walkthrough at

Biolabs specialises in bioanalysis of small molecules and
biologics for PK, immunogenicity, biomarkers and
immunological pharmacodynamics assessments utilising
LC-MS/MS, immunoassay (Mesoscale, Gyrolab, Luminex) and flow
cytometry (BD FACSymphony A3, 20 colour cell

Agilex offers pharmacodynamics services
that include immunobiology services using the latest
state-of-the-art technology to support immunology, cell
biology and mode of action assays, including:


– Receptor occupancy

Cytokine release assays (whole blood or PBMC stimulation
assays) and cytokine/biomarker profiling

– PBMC assays
and cellular mechanism of action

© Scoop Media


Source link

- Advertisment -
Times of Georgia Times of Georgia Times of Georgia

Most Popular